Skip to main content

Cart, 0 Items

Subtotal (USD):$0.00
Your cart is empty
After you’ve made a selection, review it here before checking out.
Search titles
World Book Day sale | Save 30% on your order* | Enter code WORLD at checkout | April 20- April 24 | Exclusions Apply | Save now
    Cover of GUIDE TO BIOSIMILARS LITIGATION AND REGULATION IN THE UNITED STATES SUB

    Guide To Biosimilars Litigation and Regulation In The United States, 2025-2026 ed.

    Author: Goodwin
    Format
    Purchase options
    Quantity
    Availability:
    In stock
    eBook - Monthly subscription - 2 year (24-month term): Monthly subscription - 2 year (24-month term): Get this edition including updates for a fixed monthly fee. Learn more
    $21.00 USD
    per month

    PROVIEW GUIDE TO BIOSIMILARS LITIGATION AND REGULATION IN THE US SUB

    Format

    eBook

    Purchase option

    Monthly subscription - 2 year (24-month term)

    Quantity

    1

    Total

    $21.00

    /month

    Product details
    Description

    Guide to Biosimilars Litigation and Regulation in the U.S. is an understandable guide and go-to reference, providing expert and practical guidance for attorneys working in this burgeoning area of the law.


    The title explores each section of the Biologics

    Publisher:Thomson West
    Service Number:42739749
    Publication date:2024-11-13
    Practice area:Intellectual property law
    Jurisdiction:National
    External Product Title:PROVIEW GUIDE TO BIOSIMILARS LITIGATION AND REGULATION IN THE US SUB
    Update frequency:As changes in the law dictate
    Update Format:N/A
    Subscription Number:42741350
    Available Formats:eBook
    Shelf space:0
    Author:
    Icon Purchase your preferred title and enroll in automatic updates Icon Updates, supplements and new editions for the title will be sent automatically Icon Receive on average of 20% - 30% off the standard update price
    Publication Frequency: As changes in the law dictate
    Updated Format: N/A

     

    Purchase this edition with Smart Saver - Automatic Print Updates

     

    • After initial Smart Saver purchase, automatically receive all future updates (new editions, revisions, pocket part updates, etc.) at an average discount of 20% - 30% off list price
    • After submitting your order, your bank may ask you to authenticate your purchase. Your card will not be charged until your order has been fulfilled/dispatched.
    • For returns or cancellation, refer to Terms and Conditions.
    • To contact us

     

     

     

    Publication Frequency: As changes in the law dictate
    Updated Format: N/A


    ProView is the way to read Thomson Reuters eBooks and eLooseleafs, published primarily for legal, accounting, human resources, and tax professions. The Thomson Reuters ProView web-based application is accessed via your browser. With the new ProView web-app, offline capability is now available from your browser. The web application has a responsive design and is compatible with desktop, laptop, and mobile devices.

     

    Get started with ProView training

    Publication Frequency: As changes in the law dictate
    Updated Format: N/A


    All monthly subscriptions are subject to a continuous subscription agreement meaning your subscription will automatically renew in future years unless you tell us otherwise.

     

    Each Automatic Renewal Term will be 1 month in length (“Automatic Renewal Term”) and we will notify you of any changes - including your new price - at least 10 days before each Automatic Renewal Term begins. Either of us may cancel in writing at least 30 days before an Automatic Renewal Term starts.

     

    All updates are included in your monthly subscription and will be delivered automatically as soon as they become available.

     

    Read our Terms and Conditions.

    Goodwin

    Goodwin is an AmLaw 50 law firm with more than 1,100 attorneys across the United States, Europe, and Asia. We excel at complex transactions, high stakes litigation, and world class advisory services in the life sciences, private equity, real estate,